{"pmid":32437014,"title":"A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.","text":["A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.","Currently, coronavirus disease 2019 (COVID-19) is a global pandemic disease with significant morbidity and mortality. Ozone may exert its antiviral actions and ozone therapy has been demonstrated therapeutically usefulness in influenza and novel viruses. In this letter, two severe cases with COVID-19 received ozone therapy were described. The results showed that ozone therapy may promote recovery of clinical condition and improvement of chest CT images, shorten the duration of viral shedding and length of hospital stay. This article is protected by copyright. All rights reserved.","J Med Virol","Zheng, Zhishui","Dong, Minglin","Hu, Ke","32437014"],"abstract":["Currently, coronavirus disease 2019 (COVID-19) is a global pandemic disease with significant morbidity and mortality. Ozone may exert its antiviral actions and ozone therapy has been demonstrated therapeutically usefulness in influenza and novel viruses. In this letter, two severe cases with COVID-19 received ozone therapy were described. The results showed that ozone therapy may promote recovery of clinical condition and improvement of chest CT images, shorten the duration of viral shedding and length of hospital stay. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Zheng, Zhishui","Dong, Minglin","Hu, Ke"],"date":"2020-05-22T11:00:00Z","year":2020,"_id":"32437014","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/jmv.26040","keywords":["coronavirus < virus classification","reovirus < virus classification","sars coronavirus < virus classification"],"e_drugs":["Ozone"],"topics":["Treatment"],"weight":1,"_version_":1667521393656332288,"score":9.490897,"similar":[{"pmid":32384798,"title":"Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.","text":["Potential Cytoprotective Activity of Ozone Therapy in SARS-CoV-2/COVID-19.","(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-kappa B/Nrf2 pathways and IL-6/IL-1beta expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-kappa B/Nrf2 balance and IL-6 and IL-1beta expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed.","Antioxidants (Basel)","Martinez-Sanchez, Gregorio","Schwartz, Adriana","Donna, Vincenzo Di","32384798"],"abstract":["(1) Background: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China at the end of 2019 has caused a large global outbreak. Systemic ozone therapy (OT) could be potentially useful in the clinical management of several complications secondary to SARS-CoV-2. The rationale and mechanism of action has already been proven clinically in other viral infections and has been shown in research studies to be highly effective at decreasing organ damage mediated by inflammation and oxidative stress. This review summarizes the OT studies that illustrate the possible cytoprotective mechanism of action of ozone and its physiological by-products in target organs affected by SARS-CoV-2. (2) Methods: This review encompasses a total of 74 peer-reviewed original articles. It is mainly focused on ozone as a modulator of the NF-kappa B/Nrf2 pathways and IL-6/IL-1beta expression. (3) Results: In experimental models and the few existent clinical studies, homeostasis of the free radical and antioxidant balance by OT was associated with a modulation of NF-kappa B/Nrf2 balance and IL-6 and IL-1beta expression. These molecular mechanisms support the cytoprotective effects of OT against tissue damage present in many inflammatory diseases, including viral infections. (4) Conclusions: The potential cytoprotective role of OT in the management of organ damage induced by COVID-19 merits further research. Controlled clinical trials are needed."],"journal":"Antioxidants (Basel)","authors":["Martinez-Sanchez, Gregorio","Schwartz, Adriana","Donna, Vincenzo Di"],"date":"2020-05-10T11:00:00Z","year":2020,"_id":"32384798","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3390/antiox9050389","keywords":["keap1/nrf2/are pathway","nf-kappa b","nrf2","sars-cov-2","ozone therapy 1"],"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ozone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1666340102023938048,"score":213.5074},{"pmid":32462858,"title":"Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.","text":["Oxygen-ozone therapy as adjuvant in the current emergency in SARS-COV-2 infection: a clinical study.","The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially.","J Biol Regul Homeost Agents","Marini, S","Maggiorotti, M","Dardes, N","Bonetti, M","Martinelli, M","Re, L","Carinci, F","Tavera, C","32462858"],"abstract":["The aim of the multicentre study promoted by Nuova FIO is to evaluate the beneficial effects of the systemic Oxygen-Ozone (O2O3) therapy in patients suffering from SARS COV-2 disease in the early phases of the disease, before worsening, up to the need of tracheal intubation. The study is based on the rationale on that the systemic oxygen-ozone treatment could be effective, positively influencing the disease evolution and/or being able to mitigate the onset of the cytokine storm syndrome at least partially."],"journal":"J Biol Regul Homeost Agents","authors":["Marini, S","Maggiorotti, M","Dardes, N","Bonetti, M","Martinelli, M","Re, L","Carinci, F","Tavera, C"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32462858","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.23812/20-250-E-56","keywords":["covid-19","sars-cov-2","clinical study","oxygen-ozone","protocol"],"e_drugs":["Ozone"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521519108096,"score":209.02979},{"pmid":32480061,"title":"Increased ozone levels during the COVID-19 lockdown: Analysis for the city of Rio de Janeiro, Brazil.","text":["Increased ozone levels during the COVID-19 lockdown: Analysis for the city of Rio de Janeiro, Brazil.","The first COVID-19 case in Brazil was confirmed on February 25, 2020. Partial lockdown measures came into force in the city of Rio de Janeiro, Brazil, on March 23. While CO and NO2 levels showed significant reductions, PM10 levels were only reduced in the first partial lockdown week. By contrast, ozone levels increased in all studied locations. In this study, the factors leading to this behavior were analyzed. Monitoring data obtained at two automatic monitoring stations showed higher ratios between non-methane hydrocarbons and nitrogen oxides (NMHC/NOx) during the partial lockdown (up to 37.3%). The increase in ozone concentrations during the social distancing measures could be attributed to the increase in NMHC/NOx ratios since atmospheric chemistry in Rio de Janeiro is under VOC-controlled conditions. However, the increase was higher when air masses arrived from the industrial areas, not only because of the higher NMHC/NOx ratios, but also because the reactivity of VOC was highly increased by these air masses, which are rich in aromatic compounds.","Sci Total Environ","Siciliano, Bruno","Dantas, Guilherme","da Silva, Cleyton M","Arbilla, Graciela","32480061"],"abstract":["The first COVID-19 case in Brazil was confirmed on February 25, 2020. Partial lockdown measures came into force in the city of Rio de Janeiro, Brazil, on March 23. While CO and NO2 levels showed significant reductions, PM10 levels were only reduced in the first partial lockdown week. By contrast, ozone levels increased in all studied locations. In this study, the factors leading to this behavior were analyzed. Monitoring data obtained at two automatic monitoring stations showed higher ratios between non-methane hydrocarbons and nitrogen oxides (NMHC/NOx) during the partial lockdown (up to 37.3%). The increase in ozone concentrations during the social distancing measures could be attributed to the increase in NMHC/NOx ratios since atmospheric chemistry in Rio de Janeiro is under VOC-controlled conditions. However, the increase was higher when air masses arrived from the industrial areas, not only because of the higher NMHC/NOx ratios, but also because the reactivity of VOC was highly increased by these air masses, which are rich in aromatic compounds."],"journal":"Sci Total Environ","authors":["Siciliano, Bruno","Dantas, Guilherme","da Silva, Cleyton M","Arbilla, Graciela"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32480061","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1016/j.scitotenv.2020.139765","keywords":["covid-19","lockdown","nitrogen dioxide","non-methane hydrocarbons","ozone"],"locations":["Brazil","Rio de Janeiro","Brazil","Rio de Janeiro","Rio de Janeiro","Brazil"],"countries":["Brazil"],"countries_codes":["BRA|Brazil"],"weight":0,"_version_":1668437835189846016,"score":169.74377},{"pmid":32297985,"title":"Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China.","text":["Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China.","The aim of our study was to evaluate the therapeutic effect of antiviral drugs on COVID-19 pneumonia. Patients confirmed with COVID-19 pneumonia were enrolled and divided into 7 groups according to the treatment option. Information including age, gender and duration from illness onset to admission, clinical manifestations and laboratory data at admission, and length of hospital stay were evaluated. The chest CT imaging obtained at admission and after a 5-d treatment cycle were assessed. The clinical symptoms and laboratory tests at discharge were also assessed. At admission, no significant differences were found among the groups, including duration from illness onset to admission, clinical symptoms and main laboratory results. No significant differences were found among the groups in terms of the proportion of patients with pneumonia resolution (P=0.151) after treatment or the length of hospital stay (P=0.116). At discharge, 7/184 (4%) patients had a mild cough while their other symptoms had disappeared, and the proportion of patients with abnormal liver function and with increased leucocytes, neutrophils or erythrocyte sedimentation rate among the 184 patients were close to those at admission. According to the results, the inclusion of antiviral drugs in therapeutic regimens based on symptomatic treatment had no significant additional impact on the improvement in COVID-19 patients. In addition, the results of chest CT imaging, clinical manifestations, and laboratory tests at discharge were not completely consistent. This article is protected by copyright. All rights reserved.","J Med Virol","Shi, Xiudong","Lu, Yang","Li, Rong","Tang, Yanlin","Shi, Nannan","Song, Fengxiang","Shan, Fei","Chen, Guochao","Song, Pengrui","Shi, Yuxin","32297985"],"abstract":["The aim of our study was to evaluate the therapeutic effect of antiviral drugs on COVID-19 pneumonia. Patients confirmed with COVID-19 pneumonia were enrolled and divided into 7 groups according to the treatment option. Information including age, gender and duration from illness onset to admission, clinical manifestations and laboratory data at admission, and length of hospital stay were evaluated. The chest CT imaging obtained at admission and after a 5-d treatment cycle were assessed. The clinical symptoms and laboratory tests at discharge were also assessed. At admission, no significant differences were found among the groups, including duration from illness onset to admission, clinical symptoms and main laboratory results. No significant differences were found among the groups in terms of the proportion of patients with pneumonia resolution (P=0.151) after treatment or the length of hospital stay (P=0.116). At discharge, 7/184 (4%) patients had a mild cough while their other symptoms had disappeared, and the proportion of patients with abnormal liver function and with increased leucocytes, neutrophils or erythrocyte sedimentation rate among the 184 patients were close to those at admission. According to the results, the inclusion of antiviral drugs in therapeutic regimens based on symptomatic treatment had no significant additional impact on the improvement in COVID-19 patients. In addition, the results of chest CT imaging, clinical manifestations, and laboratory tests at discharge were not completely consistent. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Shi, Xiudong","Lu, Yang","Li, Rong","Tang, Yanlin","Shi, Nannan","Song, Fengxiang","Shan, Fei","Chen, Guochao","Song, Pengrui","Shi, Yuxin"],"date":"2020-04-17T11:00:00Z","year":2020,"_id":"32297985","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1002/jmv.25893","keywords":["covid-19 pneumonia","ct imaging","antiviral drug","therapeutic effect"],"locations":["Shanghai","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1666138493256990721,"score":145.1253},{"pmid":32303365,"pmcid":"PMC7156242","title":"Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.","text":["Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19.","Pneumonia caused by coronavirus, which originated in Wuhan, China, in late 2019, has been spread around the world already becoming a pandemic. Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19. Many of these patients deteriorate rapidly and require intubation and are mechanically ventilated, which is causing the collapse of the health system in many countries due to lack of ventilators and intensive care beds. In this document we review two simple adjuvant therapies to administer, without side effects, and low cost that could be useful for the treatment of acute severe coronavirus infection associated with acute respiratory syndrome (SARS-CoV-2). VitaminC, a potent antioxidant, has emerged as a relevant therapy due to its potential benefits when administered intravenous. The potential effect of vitaminC in reducing inflammation in the lungs could play a key role in lung injury caused by coronavirus infection. Another potential effective therapy is ozone: it has been extensively studied and used for many years and its effectiveness has been demonstrated so far in multiples studies. Nevertheless, our goal is not to make an exhaustive review of these therapies but spread the beneficial effects themselves. Obviously clinical trials are necessaries, but due to the potential benefit of these two therapies we highly recommended to add to the therapeutic arsenal.","Rev Esp Anestesiol Reanim","Hernandez, A","Papadakos, P J","Torres, A","Gonzalez, D A","Vives, M","Ferrando, C","Baeza, J","32303365"],"abstract":["Pneumonia caused by coronavirus, which originated in Wuhan, China, in late 2019, has been spread around the world already becoming a pandemic. Unfortunately, there is not yet a specific vaccine or effective antiviral drug for treating COVID-19. Many of these patients deteriorate rapidly and require intubation and are mechanically ventilated, which is causing the collapse of the health system in many countries due to lack of ventilators and intensive care beds. In this document we review two simple adjuvant therapies to administer, without side effects, and low cost that could be useful for the treatment of acute severe coronavirus infection associated with acute respiratory syndrome (SARS-CoV-2). VitaminC, a potent antioxidant, has emerged as a relevant therapy due to its potential benefits when administered intravenous. The potential effect of vitaminC in reducing inflammation in the lungs could play a key role in lung injury caused by coronavirus infection. Another potential effective therapy is ozone: it has been extensively studied and used for many years and its effectiveness has been demonstrated so far in multiples studies. Nevertheless, our goal is not to make an exhaustive review of these therapies but spread the beneficial effects themselves. Obviously clinical trials are necessaries, but due to the potential benefit of these two therapies we highly recommended to add to the therapeutic arsenal."],"journal":"Rev Esp Anestesiol Reanim","authors":["Hernandez, A","Papadakos, P J","Torres, A","Gonzalez, D A","Vives, M","Ferrando, C","Baeza, J"],"date":"2020-04-19T11:00:00Z","year":2020,"_id":"32303365","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.redar.2020.03.004","keywords":["covid-19","ozone","ozono","sars-cov-2","vitamin c","vitamina c"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Ozone","Ascorbic Acid"],"topics":["Treatment"],"weight":1,"_version_":1666138491047641089,"score":138.5346}]}